January 7, 2025 - 02:06

Nvidia has officially launched its highly anticipated RTX 50 series of graphics chips during the CES 2025 event. This new lineup includes a range of powerful desktop and laptop graphics cards, with the flagship model, the RTX 5090, priced at $1,999.
The RTX 50 series promises significant advancements in gaming performance, featuring cutting-edge technology that enhances ray tracing capabilities and overall rendering quality. Gamers can expect smoother frame rates and more immersive experiences, thanks to the improved architecture and increased processing power of these new chips.
In addition to the RTX 5090, Nvidia has introduced several other models in the series, catering to a variety of gaming needs and budgets. The company emphasizes its commitment to pushing the boundaries of graphics technology, aiming to meet the demands of both casual and professional gamers alike. As the gaming landscape continues to evolve, Nvidia's RTX 50 series is poised to set new standards in visual fidelity and performance.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...